Different H2 receptor antihistamines dissimilarly retard the growth of xenografted human melanoma cells in immunodeficient mice

Cell Biology International

Volumn 26, Issue 9, 2002, Pages 833-836

  Szincsák, Nora ^a   Hegyesi, Hargita ^b   Hunyadi, Janos ^a   Falus, Andras ^b,c   Juhász, Istvan ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Histamine; Histamine antagonists; Melanoma; Tumour Growth

Indexed keywords

CIMETIDINE; CYTOCHROME P450; HISTAMINE H2 RECEPTOR ANTAGONIST; RANITIDINE; TAMOXIFEN; TESMILIFENE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; DRUG EFFECT; GROWTH RETARDATION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IN VIVO STUDY; MELANOMA CELL; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; XENOTRANSPLANTATION;

EID: 0036411827     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1065-6995(02)90934-0     Document Type: Article

References (9)

1. Adams WJ, Lawson JA, Morris DL, 1994. Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut 35: 1632-1636.
2. Bolton E, King J, Morris D, 2000. H2 antagonists in the treatment of colon and breast cancer. Seminars in Canc Biol 10: 3-10.
3. Bosma MJ, Carroll AM, 1991. The SCID mouse mutant: Definition, characterization, and potential uses. Annu Rev Immunol 9: 323-350.
4. Brandes LJ, Beecroft WA, Hogg GR, 1991. Stimulation of in vivo tumor growth and phorbol ester-induced inflammation by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]-ethanamine HCI, a potent ligand for intracellular histamine receptors. Biochem Biophys Res Commun 179: 1297-1304.
5. Cornil I, Man S, Fernandez B, Kerbel RS, 1989. Enhanced tumorigenicity, melanogenesis, and metastases of a human malignant melanoma after subdermal implantation in nude mice. J Natl Cancer Inst 81: 938-944.
6. Haak-Frendscho M, Darvas Z, Hegyesi H, Kárpáti S, Hoffmann RL, László V, Bencsáth M, Szalai C, Fürész J, Timár J, Bata-Csörg Z, Szabad G, Pivarcsi A, Pállinger E, Kemény L, Horváth A, Dobozy A, Falus A, 2000. Histidine decarboxylase expression in human melanoma. J Invest Dermatol 115: 345-352.
7. Horváth BV, Szalai C, Mándi Y, László V, Radvány, Z, Darvas Z, Falus A, 1999. Histamine and histamine-receptor antagonists modify gene expression and biosynthesis of IFN? in peripheral human blood mononuclear cells and in CD19-depleted cell subsets. Immunol Lett 70: 95-99.
8. Juhász I, Albelda SM, Elder DE, Murphy GF, Adachi K, Herlyn D, Vályi-Nagy IT, Herlyn M, 1993. Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. Am J Pathol 143: 528-537.
9. Ohtsu H, Tanaka S, Terui T, Hori Y, Makabe-Kobayashi Y, Pejler G, Tchougounova E, Hellman L, Gertsenstein M, Hirasawa N, Sakurai E, Buzás E, Kovács P, Csaba GY, Kittel A, Okada M, Hara M, Mar L, Numayama-Tsuruta K, Ishigaki-Suzuki S, Ohuchi K, Ichikawa A, Falus A, Watanabe T, Nagy A, 2001. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Letters 502: 53-57.